The Pennant Group, Inc (NASDAQ:PNTG) Accelerates Growth After Q2 Beat; Near-Term Momentum Moderates

Recent operational gains and an EPS beat pushed momentum into the second quarter, but technical indicators now show cooling momentum and a modest downside bias for the coming weeks.

Recent News

On August 5, 2026 the company reported second-quarter 2026 results and raised guidance, posting $297.98M in revenue and beating estimates. On August 4, 2026 Pennant completed an acquisition of a senior living community in Tucson, Arizona. In early June the company announced an expanded collaboration with Hartford HealthCare to advance home-based care and disclosed additions to its senior living footprint on June 3rd.

Technical Analysis

ADX stands at 20.58, indicating emerging trend strength; that emerging strength suggests directional moves now carry some conviction but lack strong extension, which tempers expectations for sustained breakout relative to the current valuation.

DI+ shows a peak-and-reverse while DI- trends lower; the DI+ peak-and-reverse signals a bearish directional shift for near-term price momentum despite ADX suggesting only an emerging trend.

MACD registers 0.06 below its 0.25 signal line and shows a peak-and-reversal pattern; that combination points to contracting bullish momentum and confirms the bearish directional cue from the DI+ reversal.

MRO stands at 16.86 with a decreasing trajectory, indicating price sits above the model target and faces downward pressure; the positive MRO level implies a measurable room for mean reversion toward valuation-based targets.

RSI at 56.38 and declining places momentum in a neutral-to-cooling range, consistent with the MACD and DI+ signals and implying limited immediate upside without a clear bullish trigger.

Price closed at $38.89, trading marginally below the 12-day and 26-day EMAs (~$39.12–$39.14) while sitting near the 20-day average ($38.97) and above the 200-day average ($32.53); the 12-day EMA shows a peak-and-reversal, implying short-term resistance above the current price despite longer-term support from the 200-day average. Bollinger bands remain tight (upper ~$39.40, lower ~$38.53), reflecting low short-term volatility and a likelihood of a consolidation or modest pullback before a directional breakout.

 


Fundamental Analysis

Total revenue for the quarter reached $297,984,000 while operating income measured $17,195,000 and net income totaled $9,082,000. EPS came in at $0.36 versus an estimate of $0.33, producing an EPS surprise of 9.09%.

WMDST values the stock as over-valued. Trailing PE stands at 102.68 and forward PE near 81.60, both reflecting elevated multiples relative to historical expectations; forward EPS sits at $0.3968. Enterprise value equals $1,766,851,244 and EV/Revenue implies a stretched enterprise multiple consistent with the over-valued assessment.

Profitability shows EBIT margin at 6.10%, which sits below the industry peer mean of 16.66% and below the industry peer median of 15.29%, indicating margin compression versus peers. EBIT margin improved QoQ by 1.50% and improved YoY by 13.67%.

Revenue dynamics present mixed signals: reported revenue growth at 4.42% (LTM) contrasts with revenue growth year-over-year of -3.93%, signaling variability across reporting periods. Operating margin stands at 5.77% and improved YoY by 20.86% though fell QoQ by 4.83%.

Balance sheet and cash metrics show $15,273,000 in cash and short-term investments, total assets of $1,037,291,000, and total debt of $493,916,000. Debt-to-assets equals 47.62% and debt-to-EBITDA measures 23.20x; interest coverage reads 5.43x. Asset turnover at 0.2989 slightly exceeds the industry peer mean of 0.2764, implying relatively efficient revenue generation from assets despite elevated leverage.

Free cash flow reached $15,494,000 with a free cash conversion ratio of 170.60% of net income; free cash flow yield registers 1.20%, roughly in line with conservative cash-return profiles and below levels that typically signal compelling yield-based valuation support.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2026-06-30
REPORT DATE: 2026-08-05
NEXT REPORT DATE: 2026-11-04
CASH FLOW  Begin Period Cash Flow 4.9 M
 Operating Cash Flow 21.8 M
 Capital Expenditures -6.34 M
 Change In Working Capital 4.8 M
 Dividends Paid
 Cash Flow Delta 10.4 M
 End Period Cash Flow 15.3 M
 
INCOME STATEMENT REVENUE
 Total Revenue 298.0 M
 Forward Revenue 113.4 M
COSTS
 Cost Of Revenue 256.1 M
 Depreciation 3.1 M
 Depreciation and Amortization 3.1 M
 Research and Development
 Total Operating Expenses 280.8 M
PROFITABILITY
 Gross Profit 41.9 M
 EBITDA 21.3 M
 EBIT 18.2 M
 Operating Income 17.2 M
 Interest Income
 Interest Expense 3.3 M
 Net Interest Income -3.35 M
 Income Before Tax 14.8 M
 Tax Provision 3.9 M
 Tax Rate 26.534 %
 Net Income 9.1 M
 Net Income From Continuing Operations 10.9 M
EARNINGS
 EPS Estimate 0.33
 EPS Actual 0.36
 EPS Difference 0.03
 EPS Surprise 9.091 %
 Forward EPS 0.40
 
BALANCE SHEET ASSETS
 Total Assets 1.0 B
 Intangible Assets 435.2 M
 Net Tangible Assets -76.03 M
 Total Current Assets 183.6 M
 Cash and Short-Term Investments 15.3 M
 Cash 15.3 M
 Net Receivables 133.2 M
 Inventory
 Long-Term Investments 27.3 M
LIABILITIES
 Accounts Payable 26.2 M
 Short-Term Debt 5.0 M
 Total Current Liabilities 152.4 M
 Net Debt 182.2 M
 Total Debt 493.9 M
 Total Liabilities 632.8 M
EQUITY
 Total Equity 359.2 M
 Retained Earnings 104.4 M
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 10.31
 Shares Outstanding 34.848 M
 Revenue Per-Share 8.55
VALUATION
 Market Capitalization 1.3 B
 Enterprise Value 1.8 B
 Enterprise Multiple 82.974
Enterprise Multiple QoQ 8.215 %
Enterprise Multiple YoY -0.586 %
Enterprise Multiple IPRWA PNTG: 82.974
high: 71.32
mean: 34.696
median: 34.394
low: 9.161
 EV/R 5.929
CAPITAL STRUCTURE
 Asset To Equity 2.888
 Asset To Liability 1.639
 Debt To Capital 0.579
 Debt To Assets 0.476
Debt To Assets QoQ 0.587 %
Debt To Assets YoY 14.149 %
Debt To Assets IPRWA high: 0.838
median: 0.815
mean: 0.66
PNTG: 0.476
low: 0.02
 Debt To Equity 1.375
Debt To Equity QoQ 5.08 %
Debt To Equity YoY 37.438 %
Debt To Equity IPRWA high: 3.407
PNTG: 1.375
mean: -5.234
median: -7.762
low: -17.523
PRICE-BASED VALUATION
 Price To Book (P/B) 3.586
Price To Book QoQ 16.18 %
Price To Book YoY 29.148 %
Price To Book IPRWA high: 7.269
PNTG: 3.586
mean: -7.638
median: -13.296
low: -17.699
 Price To Earnings (P/E) 102.685
Price To Earnings QoQ 6.894 %
Price To Earnings YoY 8.43 %
Price To Earnings IPRWA PNTG: 102.685
high: 89.218
mean: 53.943
median: 53.381
low: -16.66
 PE/G Ratio 8.215
 Price To Sales (P/S) 4.323
Price To Sales QoQ 15.501 %
Price To Sales YoY 9.07 %
Price To Sales IPRWA high: 15.055
mean: 4.679
median: 4.365
PNTG: 4.323
low: 0.158
FORWARD MULTIPLES
Forward P/E 81.596
Forward PE/G 6.528
Forward P/S 11.177
EFFICIENCY OPERATIONAL
 Operating Leverage 1.354
ASSET & SALES
 Asset Turnover Ratio 0.299
Asset Turnover Ratio QoQ 0.803 %
Asset Turnover Ratio YoY 1.795 %
Asset Turnover Ratio IPRWA high: 0.324
median: 0.324
PNTG: 0.299
mean: 0.276
low: 0.098
 Receivables Turnover 2.328
Receivables Turnover Ratio QoQ 0.314 %
Receivables Turnover Ratio YoY 1.133 %
Receivables Turnover Ratio IPRWA high: 2.963
PNTG: 2.328
mean: 1.851
median: 1.714
low: 0.6
 Inventory Turnover
Inventory Turnover Ratio QoQ
Inventory Turnover Ratio YoY
Inventory Turnover Ratio IPRWA
 Days Sales Outstanding (DSO) 39.197
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 30.093
Cash Conversion Cycle Days QoQ -1.552 %
Cash Conversion Cycle Days YoY
Cash Conversion Cycle Days IPRWA high: 133.289
PNTG: 30.093
median: 27.773
mean: -30.518
low: -410.097
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 9.555
 CapEx To Revenue -0.021
 CapEx To Depreciation -2.036
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 551.7 M
 Net Invested Capital 556.7 M
 Invested Capital 556.7 M
 Net Tangible Assets -76.03 M
 Net Working Capital 31.2 M
LIQUIDITY
 Cash Ratio 0.1
 Current Ratio 1.205
Current Ratio QoQ 1.348 %
Current Ratio YoY -0.754 %
Current Ratio IPRWA high: 2.796
PNTG: 1.205
mean: 1.191
low: 0.993
median: 0.993
 Quick Ratio
Quick Ratio QoQ
Quick Ratio YoY
Quick Ratio IPRWA
COVERAGE & LEVERAGE
 Debt To EBITDA 23.195
 Cost Of Debt 0.52 %
 Interest Coverage Ratio 5.431
Interest Coverage Ratio QoQ -2.877 %
Interest Coverage Ratio YoY -44.508 %
Interest Coverage Ratio IPRWA high: 70.154
mean: 10.216
PNTG: 5.431
median: 5.164
low: 1.576
 Operating Cash Flow Ratio 0.035
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 9.104
DIVIDENDS
 Dividend Coverage Ratio
 Dividend Payout Ratio
 Dividend Rate
 Dividend Yield
PERFORMANCE GROWTH
 Asset Growth Rate 8.448 %
 Revenue Growth 4.422 %
Revenue Growth QoQ -423.246 %
Revenue Growth YoY -3.932 %
Revenue Growth IPRWA high: 14.758 %
median: 5.866 %
mean: 5.122 %
PNTG: 4.422 %
low: -4.722 %
 Earnings Growth 12.5 %
Earnings Growth QoQ -312.513 %
Earnings Growth YoY 12.501 %
Earnings Growth IPRWA high: 63.415 %
PNTG: 12.5 %
mean: 11.52 %
median: 6.154 %
low: -60.417 %
MARGINS
 Gross Margin 14.068 %
Gross Margin QoQ 1.369 %
Gross Margin YoY 1.912 %
Gross Margin IPRWA high: 96.512 %
mean: 53.206 %
median: 44.755 %
low: 16.649 %
PNTG: 14.068 %
 EBIT Margin 6.102 %
EBIT Margin QoQ 1.497 %
EBIT Margin YoY 13.674 %
EBIT Margin IPRWA high: 57.772 %
mean: 16.659 %
median: 15.289 %
low: 6.951 %
PNTG: 6.102 %
 Return On Sales (ROS) 5.77 %
Return On Sales QoQ -4.833 %
Return On Sales YoY 20.863 %
Return On Sales IPRWA high: 33.23 %
mean: 15.988 %
median: 15.161 %
low: 7.681 %
PNTG: 5.77 %
CASH FLOW
 Free Cash Flow (FCF) 15.5 M
 Free Cash Flow Yield 1.203 %
Free Cash Flow Yield QoQ -248.153 %
Free Cash Flow Yield YoY -66.86 %
Free Cash Flow Yield IPRWA high: 4.809 %
mean: 1.552 %
median: 1.25 %
PNTG: 1.203 %
low: 0.588 %
 Free Cash Growth -278.605 %
Free Cash Growth QoQ 85.911 %
Free Cash Growth YoY 17.962 %
Free Cash Growth IPRWA high: 84.175 %
median: 23.352 %
mean: 0.248 %
PNTG: -278.605 %
low: -351.306 %
 Free Cash To Net Income 1.706
 Cash Flow Margin 1.77 %
 Cash Flow To Earnings 0.581
VALUE & RETURNS
 Economic Value Added 0.03
 Return On Assets (ROA) 0.911 %
Return On Assets QoQ 2.938 %
Return On Assets YoY -3.903 %
Return On Assets IPRWA high: 2.725 %
median: 2.725 %
mean: 2.402 %
PNTG: 0.911 %
low: 0.197 %
 Return On Capital Employed (ROCE) 2.055 %
 Return On Equity (ROE) 0.025
Return On Equity QoQ 2.681 %
Return On Equity YoY 11.809 %
Return On Equity IPRWA high: 0.177
PNTG: 0.025
mean: -0.141
median: -0.256
low: -0.347
 DuPont ROE 2.576 %
 Return On Invested Capital (ROIC) 2.399 %
Return On Invested Capital QoQ -1.316 %
Return On Invested Capital YoY -5.477 %
Return On Invested Capital IPRWA high: 6.725 %
median: 5.558 %
mean: 5.061 %
PNTG: 2.399 %
low: 0.822 %

Six-Week Outlook

Technical signals point to a short-term consolidation with a modest downside bias. Momentum indicators (MACD peak-and-reversal, DI+ peak-and-reverse, declining RSI) align with MRO’s above-target reading to suggest mean reversion risk before renewed directional conviction. Low short-term volatility and price near mid-Bollinger band indicate limited immediate range expansion absent fresh catalysts from operations, M&A, or guidance revisions. Fundamental strength from the recent EPS beat and improved margins provides a baseline of support, but elevated valuation metrics and leverage keep upside contingent on continued margin improvement and cash-flow expansion rather than solely on momentum.

About The Pennant Group, Inc.

The Pennant Group, Inc. (NASDAQ:PNTG) delivers comprehensive healthcare services across the United States. The company divides its operations into two primary segments: Home Health and Hospice Services, and Senior Living Services. Within the Home Health and Hospice segment, Pennant Group provides a range of clinical services, including nursing, speech, occupational and physical therapy, medical social work, and home health aide services. Additionally, it offers hospice services that address the physical, spiritual, and psychosocial needs of terminally ill patients and their families through clinical care, education, and counseling. In the Senior Living Services segment, the company manages residential accommodations for seniors, offering activities, meals, housekeeping, and assistance with daily living activities. These services cater to both independent seniors and those requiring additional support. The Pennant Group operates a network of home health, hospice, and home care agencies, alongside senior living communities, in states such as Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. Headquartered in Eagle, Idaho, The Pennant Group, Inc. was incorporated in 2019, establishing a robust presence in the healthcare industry.



© 2026 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.